Hostname: page-component-6bf8c574d5-mggfc Total loading time: 0 Render date: 2025-02-19T02:01:10.491Z Has data issue: false hasContentIssue false
  • English
  • Français

Sulpiride augmentation on schizophrenia

Published online by Cambridge University Press:  03 January 2018

M. Procopio
M. Procopio*
Affiliation:
The Royal London Hospital (St Clement's), 2A Bow Road, London E3 4LL
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Information
The British Journal of Psychiatry , Volume 172 , Issue 5 , May 1998 , pp. 449 - 450
Copyright
Copyright © 1998 The Royal College of Psychiatrists 

References

Buckley, P. F. (1996) Treatment of schizophrenia: advances during the decade of the brain. British Journal of Hospital Medicine. 11. 574–580.Google Scholar
Imondi, A. R., Alam, A. S., Brennen, J. J., et al (1978) Metabolism of sulpiride in man and rhesus monkeys. Archives Internationales de Pharmacodynamie et de Therapie, 232, 79–91.Google Scholar
Kane, J., Honigfeld, G., Singer, J., et al (1988) Clozapine for treatment-resistant schizophrenia: a double blind comparison with chlorpromazine. Archives of General Psychiatry, 45, 789–796.Google Scholar
Miller, D. D., Fleming, F., Hoiman, T. L., et al (1994) Plasma clozapine concentrations as a predictor of clozapine response: a follow up study. Journal of Clinical Psychiatry, 55, 117–121.Google Scholar
Shiloh, R., Zemishlany, Z., Allenberg, D., et al (1997) Sulpiride augmentation in people with schizophrenia partially responsive to clozapine. A double-blind, placebo-controlled study. British Journal of Psychiatry, 171, 569–573.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.